AGP Executive Report
Last update: 11 hours agoSTI surge: Europe has hit record levels of gonorrhoea and syphilis, with gonorrhoea up 303% since 2015 and syphilis more than doubling—ECDC warns gaps in testing and prevention are widening, including out-of-pocket test costs in some countries. Rare-disease treatment: Pharming’s Joenja (leniolisib) just got EU marketing authorization for activated PI3K delta syndrome (APDS), with access planned across EU plus Iceland and Norway. Cruise health pressure: Despite hantavirus and norovirus outbreaks on ships, cruise demand is holding up, with industry still expecting record passenger numbers. Border strain: Extra EU checks at Dover were temporarily eased after long delays in hot weather, as travellers faced waits over two hours. Iceland angle: Iceland is named among top immigrant destinations globally, and the country is included in the Joenja approval footprint. Sports-and-society: The Enhanced Games—legal PEDs, no drug tests—kick off in Las Vegas, sparking fresh debate about sport, health, and ethics.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
